Clinical Trial Economics, Policy & Industry Trends

Linking Policy Changes & Regulatory Impact to Market Access, HTA and Payer Expectations Linking Policy Changes & Regulatory Impact to Market Access, HTA and Payer Expectations The landscape of clinical research is continuously evolving, driven by changes in regulatory frameworks, health technology assessment (HTA) processes, and payer expectations. As professionals involved in clinical operations, regulatory…

Read More “Linking Policy Changes & Regulatory Impact to Market Access, HTA and Payer Expectations” »

High-Impact Policy Changes & Regulatory Impact Strategies That Protect Trial Timelines and Margins High-Impact Policy Changes & Regulatory Impact Strategies That Protect Trial Timelines and Margins The landscape of clinical research has evolved significantly over the past decade, influenced by rapid advancements in technology, changing regulatory environments, and shifts in patient-centricity. This tutorial provides a…

Read More “High-Impact Policy Changes & Regulatory Impact Strategies That Protect Trial Timelines and Margins” »

Policy Changes & Regulatory Impact in Practice: Benchmarks, Case Studies and Playbooks Policy Changes & Regulatory Impact in Practice: Benchmarks, Case Studies and Playbooks Understanding the Landscape of Clinical Trial Regulation In the complex world of clinical research, understanding the evolving landscape of regulations is imperative for successful navigation. Regulatory bodies such as the FDA,…

Read More “Policy Changes & Regulatory Impact in Practice: Benchmarks, Case Studies and Playbooks” »

How to Model Policy Changes & Regulatory Impact for Global Study Portfolios How to Model Policy Changes & Regulatory Impact for Global Study Portfolios As the landscape of clinical research continues to evolve, professionals in clinical operations, regulatory affairs, and medical affairs must be equipped to navigate the complexities surrounding policy changes and regulatory impacts….

Read More “How to Model Policy Changes & Regulatory Impact for Global Study Portfolios” »

Policy Changes & Regulatory Impact: What Clinical Leaders Need to Know Now In clinical research, adherence to regulatory requirements is paramount, particularly in a rapidly evolving policy landscape. This guide serves as a comprehensive resource for clinical operations, regulatory affairs, and medical affairs professionals who must navigate policy changes and their implications on clinical trials….

Read More “Policy Changes & Regulatory Impact: What Clinical Leaders Need to Know Now” »

Governance Models and Cross-Functional Ownership for Policy Changes & Regulatory Impact Governance Models and Cross-Functional Ownership for Policy Changes & Regulatory Impact In the landscape of biopharmaceutical development, the integration of governance models and cross-functional ownership is critical for ensuring effective policy changes and navigating the regulatory impact. This comprehensive guide aims at clinical operations,…

Read More “Governance Models and Cross-Functional Ownership for Policy Changes & Regulatory Impact” »

Using Real-World Data to Inform Policy Changes & Regulatory Impact Decisions Using Real-World Data to Inform Policy Changes & Regulatory Impact Decisions Real-world data (RWD) has become increasingly important in clinical research as it helps inform policy changes and regulatory impact decisions. Its significance in drug development, especially in edge clinical trials, has grown considerably…

Read More “Using Real-World Data to Inform Policy Changes & Regulatory Impact Decisions” »

Regulatory and Policy Shifts Reshaping Policy Changes & Regulatory Impact in the US, EU and UK Regulatory and Policy Shifts Reshaping Policy Changes & Regulatory Impact in the US, EU and UK The landscape of clinical trials is experiencing significant changes influenced by both regulatory updates and policy shifts across the US, UK, and EU….

Read More “Regulatory and Policy Shifts Reshaping Policy Changes & Regulatory Impact in the US, EU and UK” »